Changda International Holdings receives first commercial order for Thiophene from Sanofi Aventis Changda International Holdings , the Weifang based specialty chemicals producer has received an initial commercial order for this product Thiophene from Sanofi Aventis , the French pharmaceutical multinational. The order was preceded by a rigid due diligence process undertaken by Sanofi on Changda International and its own products.Release of generic Fusilev for InjectionFDA accepts Chiasma'july 30 s NDA filing for octreotide capsules for treatment of adult individuals with acromegalyOn, 2008, Sepracor Inc., UCB S.A., and UCB, Inc. Filed match in the U.S. District Courtroom for the Eastern District of NEW YORK to prevent the business from proceeding with the commercialization of its item. This step formally initiates the patent problem process beneath the Hatch-Waxman Act. Xyzal got annual sales of around $74 million in the U.S., predicated on IMS product sales data for the twelve month period closing May 2008.
CentraState chooses Cognizant to develop ICD-10 transition strategy Cognizant , a respected provider of information technology, consulting, and business procedure outsourcing services, announced that it has been selected by CentraState Health care System today, a respected not-for-profit community health organization, to develop a technique for transitioning to ICD-10.